
Synta Pharmaceuticals (NASDAQ: SNTA) has announced a definitive merger agreement with Madrigal Pharmaceuticals under which the newly-formed company will focus …

US biopharma firm Synta Pharmaceuticals has confirmed that Anne Whitaker is joining the company as president and chief executive. Whitaker …
Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

